Analysts Offer Insights on Healthcare Companies: Ramsay Health Care (OtherRMSYF) and Paradigm Biopharmaceuticals Ltd. (OtherPBIGF)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ramsay Health Care (RMSYFResearch Report) and Paradigm Biopharmaceuticals Ltd. (PBIGFResearch Report).

Ramsay Health Care (RMSYF)

Laaman has an average return of 1.0% when recommending Ramsay Health Care.

According to, Laaman is ranked #5982 out of 7906 analysts.

The word on The Street in general, suggests a Hold analyst consensus rating for Ramsay Health Care with a $55.75 average price target.

See the top stocks recommended by analysts >>

Paradigm Biopharmaceuticals Ltd. (PBIGF)

The company’s shares closed last Tuesday at $0.67, close to its 52-week low of $0.67.

According to, Hester is a 1-star analyst with an average return of -20.7% and a 0.0% success rate. Hester covers the Healthcare sector, focusing on stocks such as Volpara Health Technologies Ltd., Pro Medicus Limited, and Nanosonics Limited.

Currently, the analyst consensus on Paradigm Biopharmaceuticals Ltd. is a Moderate Buy with an average price target of $1.29.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on RMSYF:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed